HER-2 Positive Breast Cancer
1 competing product in clinical development for HER-2 Positive Breast Cancer.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eribulin + carboplatin + trastuzumab | Eisai | Phase 1/2 | Terminated | 24 |